EFFECTS OF HEALTH-SEEKING BEHAVIOR ON COMPLIANCE OF LONG-TERM TREATMENT AMONG GLAUCOMA PATIENTS
Keywords:Adherence, Socioeconomic determinants, Self-medication, Doctor-patient communication
Objectives: The objectives of the study were to determine the level of non-compliance with long-term glaucoma therapy in patients presenting in glaucoma department of Al-Shifa Trust Eye Hospital and to identify the health-seeking predictors affecting it.
Methods: A cross-sectional study of 5 months was conducted on glaucoma patients who are taking follow-up visits in glaucoma department for 6 months or more. The level of compliance with glaucoma medication (dependent variable) was assessed through a scale at first and further transformed into binary variable afterward. Chi-square test of independence was used followed by logistic regression to find out the predictors of compliance.
Results: A total of 200 patients participated in the study. Majority of them were from urban background (n=125, 62.5%) and were diagnosed with glaucoma 1–5 years (n=104, 52%) back. Almost 16.00% of patients were not giving follow-up on given appointment. Moreover, 10.00% were not taking proper medications and prescribed dosage of medications was not taken by 21.5%. Intraocular pressure was higher than normal limits in 13.00%. Self-medication (χ2 (df) =5.44(1), 0.01, OR=0.28 (0.09–0.81) and doctor-patient communication (χ2(df)=18.25(1), 0.03, OR= 2.27 (1.06– 4.86) were significant health-seeking predictors of glaucoma treatment compliance.
Conclusion: Blindness due to glaucoma is an avoidable condition if underlying factors such as self-medication is discouraged and doctor-patient communication can be improved in the glaucoma department.
Bathija R, Gupta N, Zangwill L, Weinreb R. Changing definition of glaucoma. J Glaucoma 1998;7:165-9.
Tham Y, Li X, Wong T, Quigley H, Aung T, Cheng C. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology 2014;121:2081-90.
World Health Organization. The Global Impact of Glaucoma. Geneva: World Health Organization; 2020. Available from: https://www.who.int/ blindness/publications/glaucoma/en [Last accessed on 2020 Oct 12].
Quigley H. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-7.
Chan E, Li X, Tham Y, Liao J, Wong T, Aung T, et al. Glaucoma in Asia: Regional prevalence variations and future projections. Br J Ophthalmol 2015;100:78-85.
Half of 1.8mn Glaucoma Patients in Pakistan Already Blind; 2020. Available from: https://www.dawn.com/news/612360 [Last accessed on 2020 April 19].
Available from: https://www.collinsdictionary.com/dictionary/english/ compliance
Informed Health. Treatment Options for Glaucoma. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2012.
Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW. Compliance barriers in glaucoma: A systematic classification. J Glaucoma 2003;12:393-8.
Kosoko O, Quigley H, Vitale S, Enger C, Kerrigan L, Tielsch J. Risk factors for noncompliance with glaucoma follow-up visits in a residents’ eye clinic. Ophthalmology 1998;105:2105-11.
Abu Hussein N, Eissa I, Abdel-Kader A. Analysis of factors affecting patients’ compliance to topical antiglaucoma medications in Egypt as a developing country model. J Ophthalmol 2015;2015:1-7.
Khan H, Mahsood Y, Gul N, Ilyas O, Jan S. Factors responsible for non-compliance of glaucoma patients to topical medications in our setup. Pak J Ophthalmol 2018;34:265.
Dreer L, Girkin C, Mansberger S. Determinants of medication adherence to topical glaucoma therapy. J Glaucoma 2012;21:234-40.
Taylor SA, Galbraith SM, Mills RP. Causes of non-compliance with drug regimens in glaucoma patients: A qualitative study. J Ocul Pharmacol Ther 2002;18:401-9.
Nordmann JP, Auzanneau N, Ricard S, Berdeaux G. Vision related quality of life and topical glaucoma treatment side effects. Health Qual Life Outcomes 2003;1:75.
Nayak NV, Lin J, Forster S, Tsai JC. Assessment of barriers to medication adherence and follow-up exams in glaucoma patients. Invest Ophthalmol Vis Sci 2012;53:4485.
Clewley D, Rhon D, Flynn T, Koppenhaver S, Cook C. Health seeking behavior as a predictor of healthcare utilization in a population of patients with spinal pain. PLoS One 2018;13:e0201348.
Al-Shifa Trust Eye Hospital Pakistan; 2020. Available from: https:// www.alshifaeye.org [Last accessed on 2020 Oct 08].
OpenEpi Menu; 2020. Available from: https://www.openepi.com/ menu/oe_menu.htm [Last accessed on 2020 Oct 12].
Castro AN, Mesquita WA. Noncompliance with drug therapy of glaucoma: A review about intervening factors. Braz J Pharm Sci 2009;45:453-9.
Robin AL, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology 2005;112:863-8.
Muir K, Santiago-Turla C, Stinnett S, Herndon L, Allingham R, Challa P, et al. Health literacy and adherence to glaucoma therapy. Am J Ophthalmol 2006;142:223-6.e2.
Jahan F, Siddiqui H. Good communication between doctor-patient improves health outcome. Eur J Med Health Sci 2019;1. Doi: https:// doi.org/10.24018/ejmed.2019.1.4.84.
Hussain S, Malik F, Hameed A, Ahmed S, Riaz H, Abbasi N, et al. Pakistani pharmacy students’ perception about complementary and alternative medicine. Am J Pharm Educ 2012;76:21.
Doctor/Patient Relationship Key to Glaucoma Therapy Compliance; 2021. Available from: https://www.healio.com/news/ optometry/20120225/doctor-patient-relationship-key-to-glaucoma-therapy-compliance [Last accessed on 2020 Apr 02].
Byrne J. Doctor/Patient Relationship Key to Glaucoma Therapy Compliance; 2020. Available from: https://www.healio.com/optometry/ glaucoma/news/print/primary-care-optometry-news/%7bdaf332ce-b296-47aa-8b78-d1bebba169f2%7d/doctorpatient-relationship-key-to-glaucoma-therapy-compliance [Last accessed on 2020 Apr 19].
Taylor S, Galbraith S, Mills R. Causes of non-compliance with drug regimens in glaucoma patients: A qualitative study. J Ocul Pharmacol Ther 2002;18:401-9.
Granstrom P. Glaucoma patients not compliant with their drug therapy: Clinical and behavioural aspects. Br J Ophthalmol 1982;66:464-70.
Silva L, de Paula J, Rocha E, Rodrigues M. Factors related to glaucoma treatment compliance: Patients’ opinions from a University Hospital. Arq Bras Oftalmol 2010;73:116-9.
Bloch S, Rosenthal A, Friedman L, Caldarolla P. Patient compliance in glaucoma. Br J Ophthalmol 1977;61:531-4.
Abdujawad KW, Alhussain E, Ahmad AM, Madani FM, Bakkar SA, Abduljawad KW. Compliance of glaucoma patients to their medical treatment in Jeddah. Int J Med Res Prof 2018;4:410-9.
de Castro AN, Mesquita WA. Noncompliance with drug therapy of glaucoma: A review about intervening factors. Braz J Pharm Sci 2009;45:453-9.
Cook P, Schmiege S, Mansberger S, Kammer J, Fitzgerald T, Kahook M. Predictors of adherence to glaucoma treatment in a multisite study. Ann Behav Med 2014;4929-39.
Denis P. Adverse effects, adherence and cost-benefits in glaucoma treatment. Eur Ophthalmic Rev 2011;5:116.
Yoo S, Hwang Y. Assessment of glaucoma medication compliance. J Korean Ophthalmol Soc 2015;56:365-70.
How to Cite
Copyright (c) 2021 Midhet Nasim, Amir Zeb, Samrin Khan
This work is licensed under a Creative Commons Attribution 4.0 International License.